App-Quantinova.ai

KEYNOTE-013: an open-label, multicohort phase Ib trial of pembrolizumab in patients with advanced hematologic malignancies

Philippe Armand - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hematological malignancies

Pembrolizumab

KEYNOTE-122: phase II study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma

Victor Lee - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Nasopharyngeal carcinoma

Pembrolizumab

Role of STAT1 induced CXCL10 in tumor progression and the immune microenvironment of high-grade grade serous ovarian cancer

Katrina Au - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gynaecological cancer

N/A

The Ago-PAM GAT211 Decreases Retinal Ganglion Cell Loss in the Nee Mouse Model of Ocular Hypertension

Alex J. Straiker - Association for Ocular Pharmacology and Therapeutics (AOPT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

THE INTERACTIVE ROLE OF CYTOKINES IN CARDIOMYOCYTE SURVIVAL

P. K. Singal - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Interleukin-10

MOLECULAR TARGETING OF DCM

J. Majors - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Isoproterenol

NEW AVENUES IN THE FIGHT AGAINST ATHEROSCLEROSIS

S. Lehoux - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

THE ASSOCIATION OF EDUCATION AND OBESITY AS DETERMINANTS OF PULSE PRESSURE IN A DIABETIC POPULATION

J. Liu - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

RANDOMIZED PHASE II TRIAL TO ASSESS SAFETY AND EFFICACY OF CAPRE IN MILD-TO-SEVERE HYPERTRIGLYCERIDEMIC PATIENTS

Y. Pesant - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

CHEST COMPRESSIONS DURING SUSTAINED INFLATIONS: A NOVEL TECHNIQUE OF NEONATAL RESUSCITATION THAT IMPROVES RECOVERY AND SURVIVAL IN A NEONATAL PORCINE MODEL

M. -Reilly - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

Epinephrine

THE INFLUENZA VACCINE- PREVENTING CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS

J.A. Udell - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Acute Coronary Syndromes

N/A

THE SHORT QT SYNDROME AND SUDDEN CARDIAC DEATH

Neeraj Parakh - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ventricular arrhythmias

N/A

POTENTIAL THERAPY FOR THE PREVENTION OF SUDDEN CARDIAC DEATH

Jeffrey Goldberger - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Catecholamine

ROLE OF ENDOTHELIN-1 AND CAMKINASE II SIGNALING IN CARDIOVASCULAR COMPLICATIONS

A. K. Srivastava - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Angiology

Calcified vascular disease

Angiotensin II

CHRONIC KIDNEY DISEASE AUGMENTS CARDIOVASCULAR RISK: MODULATION OF MYOCARDIAL BLOOD FLOW REGULATION AND CYP450 ARACHIDONIC ACID METABOLITES

D. Simard - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic kidney disease

Dobutamine

TOLL-LIKE RECEPTOR 9 REGULATION OF COAGULATION IN ACUTE CORONARY ARTERY DISEASE

J. G. Filep - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

OXIDATIVE AND HYPOXIC STRESS IN SUSTAINED INFLATION RESUSCITATION IN A SWINE MODEL OF NEONATAL HYPOXIA

G.M. Schmolzer - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

glutathione

DEMOGRAPHIC CHANGES IN CONGENITAL HEART DISEASE IN THE XXI CENTURY: IMPACT ON MANAGEMENT AND OUTCOMES

A.J. Marelli - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

ATRIAL FIBRILLATION AND ITS ROLE IN COGNITIVE DECLINE

Evan L. Thacker - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Normal pressure hydrocephalus

N/A

AGING AND HEART FAILURE: UPDATE 2014

Ying Ann Chiao - World Congress on Heart Disease , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Filters

28841 Abstracts